|
WO2013005057A1
|
|
New compounds
|
|
WO2013005041A1
|
|
Tricyclic heterocyclic compounds as kinase inhibitors
|
|
WO2013001310A1
|
|
Macrocyclic compounds and their use as cdk8 inhibitors
|
|
WO2012098387A1
|
|
6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
|
|
WO2012052745A1
|
|
Combinations of pi3k inhibitors with a second anti -tumor agent
|
|
WO2012020227A1
|
|
Tricyclic compounds for use as kinase inhibitors
|
|
WO2012020217A1
|
|
Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors
|
|
WO2012020215A1
|
|
Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors
|
|
WO2013004984A1
|
|
Tricyclic compounds for use as kinase inhibitors
|
|
EP2524918A1
|
|
Imidazopyrazines derivates as kinase inhibitors
|
|
WO2011141713A1
|
|
New bicyclic compounds as pi3-k and mtor inhibitors
|
|
WO2011121317A1
|
|
Imidazothiadiazoles for use as kinase inhibitors
|
|
CA2790176A1
|
|
Triazolo [4, 5 - b] pyridin derivatives
|
|
WO2011089400A1
|
|
Inhibitors of pi3 kinase
|
|
WO2011080510A1
|
|
Tricyclic compounds for use as kinase inhibitors
|
|
EP2444084A1
|
|
Use of PI3K inibitors for the treatment of obesity
|
|
BRPI1014572A2
|
|
imidazoprazines for use as kinase inhibitors
|
|
CN102388055A
|
|
Imidazo [2, 1-b] [ 1, 3, 4 ] thiadiazole derivatives
|
